Analysts have recently evaluated Cencora and provided 12-month price targets. The average target is $281.67, accompanied by a ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on COR stock, giving a Buy rating on January 14.Invest with ...

Cencora Inc., a pharmaceutical distribution giant formerly known as AmerisourceBergen, saw its chief legal officer Elizabeth ...

Cencora (COR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Investors need to ...

Cencora Inc (COR) stock saw a modest uptick, ending the day at $242.05 which represents a slight increase of $1.16 or 0.48% from the prior close of $240.89. The stock opened at $240.9 and touched a ...

Cencora's stock has demonstrated steady growth, driven by strong quarterly earnings and a positive analyst outlook, even though it hasn't risen as much as the broader market. The company's ...

First Hawaiian Bank boosted its position in Cencora, Inc. (NYSE:COR – Free Report) by 7.0% in the fourth quarter, HoldingsChannel reports. The firm owned 10,654 shares of the company’s stock after ...

HB Wealth Management LLC increased its position in shares of Cencora, Inc. (NYSE:COR – Free Report) by 18.6% in the 4th quarter, HoldingsChannel reports. The fund owned 5,020 shares of the company’s ...

The transaction, which included $6.275 billion in cash and 2 million shares of Cencora common stock, closed in June. This acquisition has enhanced Cencora’s ability to deliver sustained growth ...

CONSHOHOCKEN, Pa., August 01, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...